[Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
Affiliations: Department of Pathology, China-Japan Union Hospital of Jilin University, Nanguan District, Changchun 13033, P.R. China, Department of Obstetrics and Gynecology, China-Japan Union Hospital of Jilin University, Nanguan District, Changchun 13033, P.R. China, Department of Pathology, The First Hospital of Jilin University, Changchun 130021, P.R. China, Department of Emergency Medicine, The First Hospital of Jilin University, Changchun 130021, P.R. China
- Published online on: June 29, 2021 https://doi.org/10.3892/ijo.2021.5237
- Article Number: 57
Copyright : © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Int J Oncol 46: [Related article:] 2277-2285, 2015; DOI: 10.3892/ijo.2015.2929
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the western blotting data shown in Fig. 5C and D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that some of the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Internatinal Journal of Oncology, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.